EXECUTIVE ENGAGEMENTS
POOL
493
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
99
Interactions with Platform & by Email
PARTICIPANTS
22
Unique # Participated
VALIDATIONS
8
Responses Validated*
COMPANIES
42
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
159
PAGES
231
EDITION
8
PRICE
USD 4950
CODE
MCP10422
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Autologous Cell Therapy estimated at US$8.9 Billion in the year 2020, is projected to reach a revised size of US$29.3 Billion by 2027, growing at a CAGR of 18.6% over the analysis period 2020-2027. Bone Marrow, one of the segments analyzed in the report, is projected to record a 18.3% CAGR and reach US$17.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Epidermis segment is readjusted to a revised 20.2% CAGR for the next 7-year period.
The Autologous Cell Therapy market in the U.S. is estimated at US$2.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2027 trailing a CAGR of 18.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 16.6% and 15.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13% CAGR.
In the global Other Sources segment, USA, Canada, Japan, China and Europe will drive the 17.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.1 Billion in the year 2020 will reach a projected size of US$3.3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.4 Billion by the year 2027.
SELECT PLAYERS
BioTime, Inc.; Brainstorm Cell Therapeutics, Inc.; Caladrius Biosciences, Inc.; Fibrocell Science, Inc.; Opexa Therapeutics, Inc.; Pharmicell Co., Ltd.; Regeneus Ltd.; TiGenix NV; TxCell S.A.; U.S. Stem Cell, Inc.; Vericel Corporation
SEGMENTS
» Application (Neurology, Orthopedic, Cancer, Wound Healing, Other Applications) » End-Use (Hospitals, Ambulatory Centers, Research Centers) » Source (Bone Marrow, Epidermis, Other Sources)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Autologous Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Autologous Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Autologous Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Bone Marrow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Bone Marrow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Bone Marrow by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Epidermis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Epidermis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Epidermis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Sources by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Sources by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Sources by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Orthopedic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Wound Healing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Wound Healing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Wound Healing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Ambulatory Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Ambulatory Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Ambulatory Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Autologous Cell Therapy by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Autologous Cell Therapy by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Autologous Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Autologous Cell Therapy by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Autologous Cell Therapy by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Autologous Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Autologous Cell Therapy by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Autologous Cell Therapy by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Autologous Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Autologous Cell Therapy by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Autologous Cell Therapy by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Autologous Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Autologous Cell Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Autologous Cell Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Autologous Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Autologous Cell Therapy by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Autologous Cell Therapy by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Autologous Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Autologous Cell Therapy by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Autologous Cell Therapy by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Autologous Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Autologous Cell Therapy by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Autologous Cell Therapy by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Autologous Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Autologous Cell Therapy by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Autologous Cell Therapy by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Autologous Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Autologous Cell Therapy by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Autologous Cell Therapy by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Autologous Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Autologous Cell Therapy by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Autologous Cell Therapy by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Autologous Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Autologous Cell Therapy by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Autologous Cell Therapy by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Autologous Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Autologous Cell Therapy by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Autologous Cell Therapy by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Autologous Cell Therapy by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Autologous Cell Therapy by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Autologous Cell Therapy by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Autologous Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 42 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com